BioSpace News Archive

Bio NC

Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and patient, provided a preliminary 2023 year-end corporate update.

January 8, 2024
·
10 min read
Medtronic Diabetes announces world’s first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor

Medtronic plc, a global leader in healthcare technology, announced CE Mark approval for the MiniMed™ 780G system with Simplera Sync™, a disposable, all-in-one continuous glucose monitor requiring no fingersticks or overtape.

January 8, 2024
·
6 min read
Domain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company

Domain Therapeutics announces the appointments of Michael Gottlieb, as its Chairman of the Board of Directors, and Anthony Johnson, M.D., as its President and Chief Executive Officer.

January 8, 2024
·
3 min read
LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

LSL Pharma Group Inc. announces that it extends until February 7, 2024 its brokered private placement through the issuance of unsecured convertible debentures at a price of $10 per debenture.

January 8, 2024
·
3 min read
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

Mural Oncology plc announced strategic changes to its ARTISTRY-6 and ARTISTRY-7 clinical trials designed to generate more meaningful clinical data for these late-stage, potentially registrational trials of nemvaleukin.

January 8, 2024
·
6 min read
Genetown

HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China

HilleVax, Inc. and Chengdu Kanghua Biological Products Co., Ltd. announced the entry into an exclusive license agreement for rights to Kangh’s hexavalent virus-like particle vaccine candidate for norovirus, referred to by HilleVax as HIL-216, outside of Greater China.

January 8, 2024
·
7 min read
Biotech Bay

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

Novotech announced that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, 2024.

January 8, 2024
·
2 min read
Drug Development

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced initiation of its phase 1, first-in-human clinical study of BT-600 in healthy adult volunteers.

January 8, 2024
·
6 min read
Biotech Bay

Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program

Corcept Therapeutics Incorporated reported preliminary, unaudited, financial results for the quarter- and year-ended December 31, 2023, provided 2024 revenue guidance and announced a stock repurchase program.

January 8, 2024
·
4 min read
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, outlined progress within its pipeline programs and key milestones for 2024.

January 8, 2024
·
8 min read